Drug resistance of Mycobacterium tuberculosis in selected urban and rural areas in Bangladesh

Scandinavian Journal of Infectious Diseases

Volumn 37, Issue 1, 2005, Pages 21-26

  Zaman, Khalequ ^a   Rahim, Zeaur ^a   Yunus, Mohammad ^a   Arifeen, Shams E ^a   Baqui, Abdullah H ^b   Sack, David A ^a   Hossain, Shahed ^a   Banu, Sayera ^a   Islam, Mohammad Akramul ^c   Ahmed, Jalaluddin ^d   Breiman, Robert F ^a   Black, Robert E ^b  

^a ICDDR B Centre for Health and Population Research   (Bangladesh)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c RESEARCH AND EVALUATION DIVISION   (Bangladesh)

^d DGHS   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ACID FAST BACTERIUM; ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BANGLADESH; CONTROLLED STUDY; COUGHING; FEMALE; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HEALTH SURVEY; HUMAN; INTERVIEW; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MORTALITY; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; POPULATION RESEARCH; RURAL AREA; SPUTUM ANALYSIS; URBAN AREA;

ADOLESCENT; ADULT; ANTITUBERCULAR AGENTS; BANGLADESH; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; POPULATION SURVEILLANCE; PREVALENCE; QUALITY CONTROL; RURAL POPULATION; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT; URBAN POPULATION;

EID: 13644262962     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540410026095     Document Type: Article

References (27)

1. Moore M, Onorato IM, McCray E, Castro KG. Trends in drug-resistant tuberculosis in the US, 1993-1996. JAMA 1997;278:833-7.
2. Pablos-Mendez A, Raviglione MC, Laszlo A, Binkin N, Rieder HL, Bustreo F, et al. Global surveillance for antituberculosis drug resistance, 1994-1997. N Engl J Med 1998;338:1641-9.
3. Espinal MA, Baez J, Soriano G, Garcia V, Laszlo A, Reingold AL, Sanchez S. Drug-resistant tuberculosis in the Dominican Republic: results of a nationwide survey. Int J Tuberc Lung Dis 1998;2:490-8.
4. World Health Organization. Anti-tuberculosis drug resistance in the world. The WHO/IUATLD global project of anti-tuberculosis drug resistance surveillance. World Health Organization, Geneva, Switzerland, 1997, WHO/TB/97.289.
5. Dooley SW, Jarvis WR, Martone WJ, Snider DE Jr. Multidrug- resistant tuberculosis [editorial]. Ann Intern Med 1992;117:257-9.
6. Rattan A, Kalia A, Ahmed N. Multidrug-resistantMycobacterium tuberculosis: molecular perspectives. Emerg Infect Dis 1998;4:195-209.
7. Espinal MA, Laserson K, Camacho M, Fusheng Z, Kim SJ, Tlali E, et al. Determinants of drug-resistant tuberculosis: analysis of 11 countries. Int J Tuberc Lung Dis 2001;5:887-93.
8. Farmer P, Bayona J, Becerra M. Multidrug resistant tuberculosis and the need for biosocial perspectives. Int J Tuberc Lung Dis 2001;5:885-6.
9. World Health Organization. Global Tuberculosis Control: Surveillance, Planning, Financing. WHO Report 2003. Geneva, Switzerland, WHO/CDS/TB/2003.316.
10. World Health Organization. Tuberculosis Control in the southeast Asia region: The regional report 2003: World Health Organization 2003, New Delhi, India, SEA/TB/260.
11. International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B). HIV surveillance in Bangladesh. Health and Science Bulletin 2003;1:1-7.
12. Deun AV, Aung KJM, Chowdhury S, Saha S, Pankaj A, Ashraf A, et al. Drug susceptibility of Mycobacterium tuberculosis in a rural area of Bangladesh and its relevance to the national treatment regimens. Int J Tuberc Lung Dis 1999;3:143-8.
13. Hossain MR, Ali MS, Alam MN, Haq SA, Amin MR, Ali AKMA, et al. Primary drug resistance pattern of M. tuberculosis: report of 101 cases. In: Abstract 20th Annual General Meeting and Scientific Seminar. The Chest and Heart Association of Bangladesh, 1998.
14. International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B). Demographic Surveillance System: Matlab Vol. 1, methods and procedures. ICDDR,B Sci Rep 9, 1978.
15. Bhatia S, Mosley WH, Faruque ASG, Chakraborty J. The Matlab Family Planning Health Services Project. Stud Fam Plan 1980;11:202-12.
16. Petroff SA. A new and rapid method for the isolation and culture of tubercle bacilli directly from the sputum and faeces. J Exp Med 1915;21:38-42.
17. Canetti G, Fox W, Khomenco A, Mahlar HT, Menon NK, Mitchison DA, et al. Advances in techniques of testing mycobacterial drug sensitivity and the use of sensitivity tests in tuberculosis control programmes. Bull WHO 1969;41: 21-43.
18. World Health Organization. Treatment of tuberculosis: Guidelines for national programmes. WHO 2003, Geneva, Switzerland, WHO/CDS/TB/2003.313.
19. World Health Organization. Guidelines for the management of drug-resistant tuberculosis. WHO, Geneva, Switzerland, WHO/TB/96.210 (Rev.1) 1998.
20. Kruuner A, Sillastu H, Danilovitsh M, Levina K, Svenson SB, Kallenius G, Hoffner E. Drug resistant tuberculosis in Estonia. Int J Tuberc Lung Dis 1998;2:130-3.
21. Frieden TR, Sterling T, Pablos-Mendez A, Kilburn JO, Cauthen GM, Dooley SW. The emergence of drug-resistant tuberculosis in New York City. N Eng J Med 1993;328: 521-6.
22. Githui WA, Juma ES, van Gorkom J, Kibuga D, Odhiambo J, Drobniewski F. Anti-tuberculosis drug resistance surveillance in Kenya, 1995. Int J Tuberc Lung Dis 1998;2:499-505.
23. Lambregts-van Weezenbeek CSB, Jansen HM, Nagelkerke NJD, van Klingeren B, Veen J. Nationwide surveillance of drug-resistant tuberculosis in the Netherlands: rates, risk factors and treatment outcome. Int J Tuberc Lung Dis 1998;2:288-95.
24. Nutini S, Tortoli E, Corrado A. Multidrug-resistant tuberculosis in the Florence province from to 1992 to 1995. Int J Tuberc Lung Dis 1998;2:484-9.
25. Varaiya A, Gogate A. Drug resistance to the first line of antitubercular regimen (a preliminary report). Ind J Pub Hlth 1998;42:126-30.
26. Heymann SJ, Brewer TF, Wilson ME, Fineberg HV. The need for global action against multidrug-resistant tuberculosis. JAMA 1999;281:2138-40.
27. Farmer P, Yong Kim J. Community based approaches to the control of multidrug resistant tuberculosis: introducing 'DOTS-plus'. Br Med J 1998;317:671-4.